vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and Energy Vault Holdings, Inc. (NRGV). Click either name above to swap in a different company.

Amarin Corp plc is the larger business by last-quarter revenue ($45.1M vs $21.9M, roughly 2.1× Energy Vault Holdings, Inc.). Amarin Corp plc runs the higher net margin — -23.3% vs -148.5%, a 125.2% gap on every dollar of revenue. On growth, Energy Vault Holdings, Inc. posted the faster year-over-year revenue change (156.4% vs 7.0%). Over the past eight quarters, Energy Vault Holdings, Inc.'s revenue compounded faster (67.9% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

Energy Vault is a global energy storage company specializing in gravity and kinetic energy based, long-duration energy storage products. Energy Vault's primary product is a gravity battery to store energy by stacking heavy blocks made of composite material into a structure, capturing potential energy in the elevation gain of the blocks. When demand for electricity is high, these blocks are lowered with the motors functioning as generators and delivering electricity to the grid.

AMRN vs NRGV — Head-to-Head

Bigger by revenue
AMRN
AMRN
2.1× larger
AMRN
$45.1M
$21.9M
NRGV
Growing faster (revenue YoY)
NRGV
NRGV
+149.4% gap
NRGV
156.4%
7.0%
AMRN
Higher net margin
AMRN
AMRN
125.2% more per $
AMRN
-23.3%
-148.5%
NRGV
Faster 2-yr revenue CAGR
NRGV
NRGV
Annualised
NRGV
67.9%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
AMRN
AMRN
NRGV
NRGV
Revenue
$45.1M
$21.9M
Net Profit
$-10.5M
$-32.5M
Gross Margin
21.9%
Operating Margin
35.5%
-32.5%
Net Margin
-23.3%
-148.5%
Revenue YoY
7.0%
156.4%
Net Profit YoY
33.0%
-53.7%
EPS (diluted)
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
NRGV
NRGV
Q1 26
$45.1M
$21.9M
Q4 25
$49.2M
Q3 25
$49.7M
$33.3M
Q2 25
$72.7M
$8.5M
Q1 25
$42.0M
$8.5M
Q4 24
$62.3M
$33.5M
Q3 24
$42.3M
$1.2M
Q2 24
$67.5M
$3.8M
Net Profit
AMRN
AMRN
NRGV
NRGV
Q1 26
$-10.5M
$-32.5M
Q4 25
$-1.2M
Q3 25
$-7.7M
$-26.8M
Q2 25
$-14.1M
$-34.9M
Q1 25
$-15.7M
$-21.1M
Q4 24
$-48.6M
$-61.8M
Q3 24
$-25.1M
$-26.6M
Q2 24
$1.5M
$-26.2M
Gross Margin
AMRN
AMRN
NRGV
NRGV
Q1 26
21.9%
Q4 25
47.1%
Q3 25
44.7%
27.0%
Q2 25
69.2%
29.6%
Q1 25
59.8%
57.1%
Q4 24
-15.4%
7.7%
Q3 24
38.5%
40.3%
Q2 24
63.4%
27.8%
Operating Margin
AMRN
AMRN
NRGV
NRGV
Q1 26
35.5%
-32.5%
Q4 25
-12.9%
Q3 25
-22.4%
-52.8%
Q2 25
-22.0%
-330.7%
Q1 25
-39.9%
-244.8%
Q4 24
-84.3%
-150.6%
Q3 24
-59.5%
-2258.1%
Q2 24
-0.8%
-739.7%
Net Margin
AMRN
AMRN
NRGV
NRGV
Q1 26
-23.3%
-148.5%
Q4 25
-2.5%
Q3 25
-15.6%
-80.5%
Q2 25
-19.4%
-410.3%
Q1 25
-37.4%
-247.7%
Q4 24
-78.0%
-184.7%
Q3 24
-59.4%
-2217.9%
Q2 24
2.3%
-694.6%
EPS (diluted)
AMRN
AMRN
NRGV
NRGV
Q1 26
$-0.20
Q4 25
$0.00
Q3 25
$-0.02
$-0.16
Q2 25
$-0.03
$-0.22
Q1 25
$-0.04
$-0.14
Q4 24
$-0.12
$-0.41
Q3 24
$-0.06
$-0.18
Q2 24
$0.00
$-0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
NRGV
NRGV
Cash + ST InvestmentsLiquidity on hand
$307.8M
$55.2M
Total DebtLower is stronger
$160.6M
Stockholders' EquityBook value
$30.5M
Total Assets
$645.8M
$298.0M
Debt / EquityLower = less leverage
5.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
NRGV
NRGV
Q1 26
$307.8M
$55.2M
Q4 25
$302.6M
Q3 25
$286.6M
$32.7M
Q2 25
$298.7M
$22.3M
Q1 25
$281.8M
$21.2M
Q4 24
$294.2M
$30.0M
Q3 24
$305.7M
$51.1M
Q2 24
$306.7M
$106.8M
Total Debt
AMRN
AMRN
NRGV
NRGV
Q1 26
$160.6M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
AMRN
AMRN
NRGV
NRGV
Q1 26
$30.5M
Q4 25
$459.3M
Q3 25
$458.9M
$80.5M
Q2 25
$464.9M
$90.3M
Q1 25
$473.7M
$114.9M
Q4 24
$486.2M
$126.3M
Q3 24
$531.4M
$179.1M
Q2 24
$551.9M
$195.6M
Total Assets
AMRN
AMRN
NRGV
NRGV
Q1 26
$645.8M
$298.0M
Q4 25
$670.8M
Q3 25
$659.8M
$281.9M
Q2 25
$670.1M
$248.8M
Q1 25
$655.7M
$217.4M
Q4 24
$685.3M
$183.9M
Q3 24
$750.6M
$252.9M
Q2 24
$799.9M
$255.6M
Debt / Equity
AMRN
AMRN
NRGV
NRGV
Q1 26
5.27×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
NRGV
NRGV
Operating Cash FlowLast quarter
$-53.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
NRGV
NRGV
Q1 26
$-53.8M
Q4 25
$15.3M
Q3 25
$-12.7M
$-11.7M
Q2 25
$16.6M
$15.4M
Q1 25
$-12.5M
$-2.7M
Q4 24
$-13.3M
$-34.8M
Q3 24
$-2.4M
$-9.2M
Q2 24
$-2.7M
$-12.8M
Free Cash Flow
AMRN
AMRN
NRGV
NRGV
Q1 26
Q4 25
Q3 25
$-27.2M
Q2 25
$6.9M
Q1 25
$-9.5M
Q4 24
$-45.4M
Q3 24
$-36.4M
Q2 24
$-25.1M
FCF Margin
AMRN
AMRN
NRGV
NRGV
Q1 26
Q4 25
Q3 25
-81.5%
Q2 25
81.6%
Q1 25
-111.5%
Q4 24
-135.5%
Q3 24
-3039.9%
Q2 24
-665.1%
Capex Intensity
AMRN
AMRN
NRGV
NRGV
Q1 26
Q4 25
Q3 25
46.4%
Q2 25
98.8%
Q1 25
79.5%
Q4 24
31.5%
Q3 24
2273.1%
Q2 24
325.8%
Cash Conversion
AMRN
AMRN
NRGV
NRGV
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

NRGV
NRGV

Segment breakdown not available.

Related Comparisons